Mrv1909 02122022382D 16 19 0 0 0 0 999 V2000 0.5175 -0.4060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.5188 0.4184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1944 0.8298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1924 -0.8174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.9016 -0.4104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.9029 0.4141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6165 0.8237 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.3296 0.4096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.3243 -0.4181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6100 -0.8240 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.9809 0.7352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3296 -0.0076 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.9627 -0.7520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1734 0.9300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1552 -0.9300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4666 -0.0112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12 13 1 0 0 0 0 5 6 1 0 0 0 0 11 14 1 0 0 0 0 2 3 1 0 0 0 0 13 15 1 0 0 0 0 14 2 1 0 0 0 0 15 1 1 0 0 0 0 6 7 1 0 0 0 0 15 16 1 0 0 0 0 16 14 1 0 0 0 0 3 6 2 0 0 0 0 7 8 2 0 0 0 0 8 9 1 0 0 0 0 5 4 2 0 0 0 0 9 10 2 0 0 0 0 10 5 1 0 0 0 0 4 1 1 0 0 0 0 1 2 2 0 0 0 0 11 12 1 0 0 0 0 M END > DB01273 > drugbank > C1C2CNCC1C1=C2C=C2N=CC=NC2=C1 > InChI=1S/C13H13N3/c1-2-16-13-5-11-9-3-8(6-14-7-9)10(11)4-12(13)15-1/h1-2,4-5,8-9,14H,3,6-7H2 > JQSHBVHOMNKWFT-UHFFFAOYSA-N > C13H13N3 > 211.268 > 211.110947431 > 3 > 29 > 0.9981314405062162 > 23.119343352344917 > 1 > 1 > 0 > 1 > 5,8,14-triazatetracyclo[10.3.1.0^{2,11}.0^{4,9}]hexadeca-2(11),3,5,7,9-pentaene > 1.39 > 1.0076279959999996 > -3.38 > 0 > 1 > 4 > 1 > 9.726333010947785 > 37.81 > 61.303 > 0 > 1 > 8.77e-02 g/l > 5,8,14-triazatetracyclo[10.3.1.0^{2,11}.0^{4,9}]hexadeca-2(11),3,5,7,9-pentaene > 1 > DB01273 > approved; investigational > Varenicline > Vareniclina; Varenicline; Vareniclinum > Apo-varenicline; Champix; Chantix; Gd-varenicline; Nra-varenicline; PMS-varenicline; Teva-varenicline; Tyrvaya; Varenicline; Varenicline Tartrate; Varenicline tartrate > Varenicline tartrate $$$$